A detailed history of Centiva Capital, LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Centiva Capital, LP holds 1,000 shares of VRTX stock, worth $516,740. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,000
Previous 2,308 56.67%
Holding current value
$516,740
Previous $964,000 51.45%
% of portfolio
0.01%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $227,436 - $281,121
579 Added 25.09%
2,887 $1.35 Million
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $535,704 - $586,149
1,314 Added 132.19%
2,308 $964,000
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $166,012 - $198,769
484 Added 94.9%
994 $404,000
Q3 2023

Nov 14, 2023

SELL
$338.18 - $362.46 $3.37 Million - $3.61 Million
-9,952 Reduced 95.13%
510 $177,000
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $3.06 Million - $3.42 Million
9,723 Added 1315.7%
10,462 $3.68 Million
Q1 2023

May 15, 2023

BUY
$283.23 - $323.1 $88,934 - $101,453
314 Added 73.88%
739 $232,000
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $15,716 - $17,681
-55 Reduced 11.46%
425 $122,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $131,438 - $146,654
480 New
480 $139,000
Q2 2022

Aug 15, 2022

BUY
$234.96 - $292.55 $5.29 Million - $6.58 Million
22,500 New
22,500 $6.34 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $2 Million - $2.24 Million
-11,053 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $1.08 Million - $1.27 Million
5,757 Added 108.7%
11,053 $2.23 Million
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $334,337 - $389,715
1,615 Added 43.87%
5,296 $1.14 Million
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $210,322 - $280,507
1,016 Added 38.12%
3,681 $870,000
Q3 2020

Nov 16, 2020

SELL
$255.65 - $303.1 $556,294 - $659,545
-2,176 Reduced 44.95%
2,665 $725,000
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $117,024 - $153,520
519 Added 12.01%
4,841 $1.41 Million
Q1 2020

May 15, 2020

SELL
$199.77 - $247.81 $1.71 Million - $2.12 Million
-8,552 Reduced 66.43%
4,322 $1.03 Million
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $138,369 - $185,845
-830 Reduced 6.06%
12,874 $2.82 Million
Q3 2019

Nov 13, 2019

BUY
$166.23 - $187.09 $2.08 Million - $2.34 Million
12,496 Added 1034.44%
13,704 $2.32 Million
Q2 2019

Aug 13, 2019

SELL
$164.61 - $190.37 $374,816 - $433,472
-2,277 Reduced 65.34%
1,208 $221,000
Q1 2019

May 14, 2019

BUY
$163.73 - $194.7 $570,599 - $678,529
3,485 New
3,485 $641,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.